Dark Forest Capital Management LP Fibrogen Inc Transaction History

Dark Forest Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$15.95 - $25.18 $40,002 - $63,151	2,508 New	2,508 $46,000
Q3 2022 Nov 14, 2022	BUY	$11.4 - $14.6 $82,159 - $105,222	7,207 Added 45043.75%	7,223 $94,000
Q2 2022 Aug 15, 2022	BUY	$7.94 - $12.96 $127 - $207	16 New	16 $0
Q1 2022 May 13, 2022	SELL	$12.02 - $16.79 $12,428 - $17,360	-1,034 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$9.93 - $15.39 $10,267 - $15,913	1,034 New	1,034 $15,000
Q3 2021 Nov 12, 2021	SELL	$10.18 - $26.64 $2,799 - $7,326	-275 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$18.57 - $35.68 $5,106 - $9,812	275 New	275 $7,000

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.